LinkedIn Voices: Demis Hassabis
Discover how Nobel Laureate Demis Hassabis advances AGI, scientific discovery, AI-driven drug discovery, and responsible AI through Google DeepMind and Isomorph
Advancing artificial general intelligence calls for a deeper understanding of intelligence, scientific discovery, and the systems that can help expand human progress. As Co-Founder and Chair of Google DeepMind, Chief Scientist at Alphabet, and Founder and CEO of Isomorphic Labs, Demis Hassabis works to advance AGI, accelerate scientific breakthroughs, and transform drug discovery while exploring the fundamental nature of reality.
Who is Demis Hassabis?
Demis Hassabis is a Nobel Laureate, computer scientist, cognitive neuroscientist, and technology entrepreneur whose career spans pioneering video game development, artificial intelligence, computational biology, and scientific research. His work includes leading the development of AlphaGo, the first program to defeat a world champion at the game of Go, and AlphaFold, which addressed the 50-year grand challenge of protein structure prediction.
Niche & Specialization
Artificial general intelligence and advanced AI systems.
Scientific discovery through artificial intelligence.
Computational biology and protein structure prediction.
AI-driven drug discovery and biopharmaceutical research.
AI safety, responsible development, and international AI governance.
Cognitive neuroscience and artificial intelligence research.
A defining aspect of Hassabis's work is his focus on understanding intelligence and using AI to accelerate scientific discovery. He has consistently explored the potential of AI to advance human progress while emphasizing the importance of scientific rigour and grounded foresight as increasingly advanced systems are developed.
His work also connects artificial intelligence with major scientific and health challenges. Through AlphaFold and Isomorphic Labs, he has applied AI to biological research and drug discovery, reflecting his belief that improving human health should be one of the most important applications of AI.
Target Audience
Scientists and researchers interested in using artificial intelligence to accelerate scientific discovery.
AI researchers and technical experts exploring artificial general intelligence and advanced AI systems.
Biopharmaceutical and biotechnology professionals interested in AI-driven drug discovery.
Policymakers and experts working on AI safety, governance, and international standards.
Professionals and researchers interested in the relationship between artificial intelligence, human intelligence, and scientific progress.
Career Journey & Achievements
Demis Hassabis began his professional career in video game development, working on the AI and design of pioneering simulation games such as Theme Park, Black & White, and Republic: the Revolution through roles at Bullfrog Productions, Lionhead Studios, and Elixir Studios. He later pursued academic research, earning a BA in Computer Science from the University of Cambridge and a PhD in Cognitive Neuroscience from UCL, followed by a research fellowship at UCL's Gatsby Computational Neuroscience Unit.
In 2010, he co-founded DeepMind, where he served as Co-Founder and CEO before becoming Co-Founder and Chair in 2026. The company developed groundbreaking AI systems including AlphaGo, the first program to defeat a world champion at the game of Go. Google acquired DeepMind in 2014, and Hassabis continued leading its work on fundamental AI progress.
Another major achievement was AlphaFold, which cracked the 50-year grand challenge of protein structure prediction. The breakthrough was recognised with the 2024 Nobel Prize in Chemistry.
Hassabis founded Isomorphic Labs in 2021, where he serves as Founder and CEO and works to reimagine drug discovery through AI. In 2026, he also became Chief Scientist at Alphabet. Through the DeepMind Institute, he is supporting cross-disciplinary research and discussion around the economic and societal implications of AGI and the challenges of the AI era.
Content Strategy & Teaching Approach
Hassabis communicates complex developments in artificial intelligence and scientific research through clear explanations, technical insights, and discussions about the opportunities and risks associated with advanced AI. His LinkedIn content covers AGI, scientific discovery, AI safety, frontier AI governance, and developments across Google's AI systems and Isomorphic Labs.
A recurring theme in his communication is the need to balance the potential of AI with responsible development. He has discussed the benefits AI could bring to science and human progress while also highlighting risks related to cybersecurity, biological security, and the broader challenges associated with advanced AI systems. He also advocates for international AI standards and grounded, scientifically rigorous approaches to understanding and mitigating these risks.
Posts on LinkedIn
Metrics & Impact
Over 379,000 followers on LinkedIn, engaging a global audience interested in artificial intelligence, science, technology, and AI governance
Awarded the 2024 Nobel Prize in Chemistry for the breakthrough in protein structure prediction through AlphaFold
Co-Founder and Chair of Google DeepMind, following his previous role as Co-Founder and CEO
Founder and CEO of Isomorphic Labs, which raised $2.1 billion in new funding to advance its work in AI-driven drug discovery
Chief Scientist at Alphabet, contributing to the development and responsible advancement of frontier AI
Media Appearance
https://www.youtube.com/watch?v=rDteJAuKiBI&pp=ygUPRGVtaXMgSGFzc2FiaXMg
Why He Matters
Demis Hassabis represents a scientific approach to artificial intelligence that connects advances in AGI with broader questions about science, health, and human progress. His work on AlphaGo demonstrated the capabilities of advanced AI systems, while AlphaFold showed how these systems can address major scientific challenges. Through Isomorphic Labs, he is applying AI to drug discovery, while his work on AI safety and international governance addresses the challenges that accompany increasingly advanced AI systems.
Profile Summary
Followers:
379,544 on LinkedIn
Startup:
Google DeepMind, Isomorphic Labs, DeepMind Institute
Mission:
To solve intelligence to advance science and benefit humanity
